Related Experiment Video

Updated: Jul 9, 2026

Phospholipid Mediator Induced Transformation in Three-Dimensional Cultures
08:02

Phospholipid Mediator Induced Transformation in Three-Dimensional Cultures

Published on: July 27, 2022

The role of insulin receptor substrate-1 in transformation by v-src

Hongzhi Sun1, Renato Baserga

  • 1Department of Cancer Biology, Thomas Jefferson University, Philadelphia, Pennsylvania 19107, USA.

Journal of Cellular Physiology
|December 8, 2007
PubMed

Insights

Down-regulation of insulin receptor substrate-1 (IRS-1) reverses cancer cell transformation by v-src. IRS-1 moves to the nucleus, activating cell cycle genes and promoting mammary cancer cell transformation.

Area of Science:

  • Molecular biology
  • Cell signaling
  • Cancer research

Background:

  • Insulin receptor substrate-1 (IRS-1) is a key docking protein for insulin (InR) and insulin-like growth factor-1 (IGF-IR) receptors.
  • IRS-1 mediates mitogenic, anti-differentiation, and transforming signals crucial for cell growth and survival.

Purpose of the Study:

  • To investigate the role of IRS-1 in v-src-mediated cellular transformation.
  • To elucidate the mechanisms by which IRS-1 contributes to the activation of cell cycle progression genes.

Main Methods:

  • Studied the effect of IRS-1 down-regulation on v-src-transformed cells.
  • Utilized techniques to track IRS-1 translocation to the nucleus.
  • Assessed promoter occupancy and gene transcription of cyclin D1 and rDNA.
  • Investigated the binding interaction between IRS-1 and v-src using tyrosine residues.

Main Results:

  • Down-regulation of IRS-1 reversed the transformed phenotype in v-src-transformed cells.
  • IRS-1 was found to translocate to the nucleus and bind to cyclin D1 and rDNA promoters.
  • IRS-1 is required, along with v-src, for Stat3 promoter occupancy.
  • IRS-1 significantly increased transcription from the cyclin D1 and rDNA promoters.
  • Specific tyrosine residues in IRS-1 are essential for its binding to v-src and mammary cancer cell transformation.

Conclusions:

  • IRS-1 plays a critical role in v-src-mediated cellular transformation.
  • IRS-1 activation of cell cycle progression genes is a key mechanism in transformation.
  • Targeting IRS-1 interactions could offer therapeutic strategies for v-src-driven cancers.

Related Concept Videos

Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Insulin Secretory Vesicles01:05

Insulin Secretory Vesicles

Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...